N@N

Celldex Therapeutics to Present at the Citi 2010 Investment Research Global Health Care Conference

^{Published on 2010-05-21 08:05:13 - Market Wire}
 

NEEDHAM, Mass.--([ BUSINESS WIRE ])--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the Citi 2010 Investment Research Global Health Care Conference at the Hilton New York in New York City on Thursday, May 27, 2010 at 2:30 pm EDT.

A live webcast of the presentation will be available on the aPresentationsa page of the aInvestorsa section of the Celldex website at [ http://www.celldextherapeutics.com ] and will be archived for 30 days following the event.

About Celldex Therapeutics, Inc.

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit [ http://www.celldextherapeutics.com ].